Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilson's disease: an update.

Shyamal K Das1, Kunal Ray

  • 1Movement Disorders Clinic, Bangur Institute of Neurology, Kolkata, India. das_sk70@hotmail.com

Nature Clinical Practice. Neurology
|August 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistically optimized liposomal formulation of dorzolamide hydrochloride for sustained ocular delivery: <i>in vitro</i> and allergic evaluation in rabbit.

Drug development and industrial pharmacy·2026
Same author

High-rate performance of H<sub></sub>MoO<sub>3</sub> for aqueous aluminium-ion batteries.

Chemical communications (Cambridge, England)·2025
Same author

A Perspective on Evaluating Life Stage Differences in Drug Dosages for Drug Labeling and Instructions.

The AAPS journal·2024
Same author

Identifying genetic defects in oculocutaneous albinism patients of West Bengal, Eastern India.

Molecular biology reports·2024
Same author

Copper tetrathiovanadate (Cu<sub>3</sub>VS<sub>4</sub>): a newly emerging electrode for rechargeable aqueous aluminum-ion batteries.

Dalton transactions (Cambridge, England : 2003)·2024
Same author

Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community's view.

EClinicalMedicine·2023

Wilson's disease (WD) is a genetic disorder of copper metabolism due to ATP7B gene mutations, causing copper buildup in organs. Current treatments involve copper chelation or liver transplant, with ongoing research for better therapies.

Area of Science:

  • Genetics and Metabolism
  • Hepatology
  • Neurology

Background:

  • Wilson's disease (WD) is an inherited disorder of copper metabolism.
  • It results from mutations in the ATP7B gene, leading to excessive copper deposition in the liver and brain.
  • Diagnosis relies on clinical signs, biochemical tests, and Kayser-Fleischer rings, with a new scoring system proposed.

Purpose of the Study:

  • To summarize the current understanding of Wilson's disease.
  • To highlight diagnostic challenges and treatment options.
  • To emphasize the need for improved therapeutic strategies.

Main Methods:

  • Review of existing literature on Wilson's disease.
  • Analysis of diagnostic criteria and genetic testing approaches.

Related Experiment Videos

  • Evaluation of current and emerging treatment modalities.

    • Main Results:

    • ATP7B gene mutations are diverse, complicating genetic defect identification.
    • Traditional treatments like D-penicillamine have side effects; trientine and ammonium tetrathiomolybdate are alternatives.
    • Orthotropic liver transplantation can be curative in severe cases.

    Conclusions:

    • Further research into ATP7B and its modifiers (ATOX1, COMMD1) is crucial for understanding genotype-phenotype correlations.
    • Development of improved drugs is anticipated to enhance patient outcomes.
    • Comprehensive management involves early diagnosis, genetic counseling, and tailored treatment.